51Âþ»­app

51Âþ»­applogo
Business Overview
 

InspiroGene by McKesson

Guiding and supporting the commercialization of cell and gene therapies.

Bridging the Gap Between Cell and Gene Therapy Innovation and Reality

In the complex world of cell and gene therapy (CGT), inefficiencies in communication, responsiveness and workflow consistency can delay patient access to critical treatments. InspiroGene by 51Âþ»­appwas created to solve these challenges by elevating the therapy experience at every touchpoint.

As an enduring ally, InspiroGene is dedicated to ensuring that patients receive the life-changing treatments they need. Through a thoughtfully designed, configurable approach, InspiroGene streamlines communication, enhances responsiveness and fosters a cohesive, consistent workflow for optimal patient outcomes.

 

Our Focus Areas

Our suite of services includes:

Icon of a warehouse with a delivery truck in front.

Icon of an open cardboard box with 'MC' and directional arrows printed on it.

Icon of a computer screen displaying a mortar and pestle with an Rx symbol.

Icon of a female user in front of a desktop computer monitor


Advancing Cell and Gene Therapy

InspiroGene by 51Âþ»­apppartners with biopharma to solve the complexities of commercializing cell and gene therapy — combining deep expertise, tailored logistics and a true understanding
of every patient and product journey.

InspiroGene Tech-Enabled Integration

We offer a suite of configurable solutions to support CGT manufacturers from clinical development to full-scale commercialization.

InspiroCare

Our Patient HUB delivers personalized support for patients and data transparency for biopharma partners.

InspiroLink

Our treatment center interface that simplifies CGT ordering, tracking and financial management across all channels.

Silver molecular structure with blue spheres and small photos on a light blue background.
Report
 

2025 Cell and Gene Therapy Report

Explore the latest trends shaping the future of cell and gene therapy and learn what’s needed to ensure innovation reaches patients.

 

Explore InspiroGene by 51Âþ»­appStories and Insights

Person in a white lab coat and glasses looks at a computer in a bright laboratory or clinical workspace.
  • Future of Healthcare
Enabling Simpler Cell and Gene Therapy Delivery

Two men looking at a laptop.
  • Business Feature
Transforming Patient Support for Cell and Gene Therapies

Joe DePinto
  • Future of Healthcare
Advancing Cell and Gene Therapy

A doctor in a white coat speaks with a patient in a bright hallway.
  • Business Feature
Breaking Barriers to Cell and Gene Therapy Access

Dark blue background with faint DNA double helix structures scattered throughout.
InspiroGene by McKesson: Cell & Gene Therapy Solutions

A doctor with a stethoscope is consulting with a seated woman in a bright office.
  • Industry Trends
Expanding Access to Cell and Gene Therapy for Patients

InspiroGene by 51Âþ»­appAdditional Resources

Stay up to date on the latest from InspiroGene by McKesson.

News & Resources

View our curated set of cell and gene therapy publications, podcasts, videos and other resources available for viewing or download.

Cell and Gene Therapy Centers Map

51Âþ»­apphas developed an interactive map of Qualified Treatment Centers (QTCs) in 109 metropolitan regions across the U.S. as a resource.

Hear From the Team

Learn more about the leadership team at InspiroGene by McKesson.

 

Learn More About McKesson’s Solutions

 
A healthcare professional in scrubs and a stethoscope comforts a person wearing a headscarf.

Oncology & Multispecialty Solutions

InspiroGene is working to expand access to cell and gene therapy treatments to improve patient outcomes.

Learn more about how 51Âþ»­appis advancing oncology and specialty care.

Shelves filled with clear plastic IV bags labeled 'NS 250' in a medical storage area.

Biopharma Capabilities

InspiroGene brings deep experience to the cell and gene therapy commercialization journey with established solutions to address the complex challenges of bringing these advanced therapies to market.

Learn more about how 51Âþ»­appis advancing biopharma solutions.